Investor mix
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Accelerator & incubator | 1 | 50% |
| Other / undisclosed | 1 | 50% |
Company developing immunoassays and preclinical biologics through their proprietary antibody engineering and protein expression technologies
2 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Accelerator & incubator | 1 | 50% |
| Other / undisclosed | 1 | 50% |